Barriers to Patients' Early Presentation, Diagnosis and Treatment in Childhood Hydrocephalus
NCT ID: NCT05796713
Last Updated: 2025-12-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2023-03-01
2024-01-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anterior Pituitary Function in Patients With Hydrocephalus
NCT00149721
Critical Congenital Heart Defect (CHD) Outcomes in Children
NCT00208689
CEUS Evaluation of Hydrocephalus in Neonates and Infants
NCT06693752
Growth Pattern and Characteristics of Cardiac Pediatric Patients
NCT05577130
Inherited Cardiac cONditions In Kids
NCT05158738
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The patients' data that will be collected will include gender, age at presentation, socioeconomic class of parents (or guardians), religion, referral source, presenting complaint with its duration, physical findings, ventricular diameter. The Pre-presentation symptoms interval (PPI) will be defined as the number of days between the onset of symptoms and first presentation at any type of healthcare service centre (including primary healthcare centre, secondary health institutions); Presentation Interval (PI)- Number of days from symptoms to presenting at Neurosurgical centre; Pre-diagnostic interval (PDI) will be defined as the interval in days between symptoms and completion of pre-operative investigations. Patient interval (PI) will be defined as the number of days from the onset of symptoms and patient's first contact with the Neurosurgical center. Hospital interval (HI)- number of days from completion of investigations to surgical intervention. The collected data will be analyzed according to qualitative conventional content analysis. Nvivo software version 13 and Statistical Product and Service Solutions (SPSS) version 23 will be used for data analysis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hydrocephalus
Interview
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hospital staff members, who have been working within the Neurosurgical unit for at least 5 years.
Exclusion Criteria
* Patients older than 5 years
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hydrocephalus Association
OTHER
Lagos State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Olufemi Idowu
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olufemi Idowu, FWACS, FACS
Role: PRINCIPAL_INVESTIGATOR
Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lagos State University Teaching Hospital
Ikeja, Lagos, Nigeria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023/Hydro
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.